Mallory Named Associate Dean for Diversity and Inclusion
Mia Mallory, MD, has been named associate dean for diversity and inclusion at the College of Medicine.
Mallory, an associate professor of pediatrics, is returning to Cincinnati after two years as an emergency physician at Childrens Healthcare of Atlanta. Previously, she served eight years as the associate residency director for pediatrics at Cincinnati Childrens Hospital Medical Center.
In her new role, Mallory will be responsible for the development and implementation of plans and programs to recruit and retain a diverse community of faculty, students and staff within the college.
In addition to chairing the diversity council, she will work with the deans office and departments to assure compliance with LCME and other applicable standards related to diversity and inclusion.
In a memo announcing the appointment, College of Medicine Dean Thomas Boat, MD, and Senior Associate Dean for Academic Affairs Andrew Filak Jr., MD, thanked Charles Collins, MD, for his work during his eight years in the associate dean position. Collins will return full time to his role as vice chair of the department of psychiatry and behavioral neuroscience.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.